One MRI scan to rule them all? new study tests organ health in diabetes

NCT ID NCT04137705

Completed Knowledge-focused Sponsor: Perspectum Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a single, standardized MRI scan can reliably measure body composition and the health of multiple organs—like the liver, pancreas, heart, and kidneys—in people with type 2 diabetes and healthy volunteers. 43 participants were scanned twice on the same machine and on different machines to check how repeatable the measurements were. The goal was to see if this approach could be a useful tool for future research or clinical care, not to treat the disease itself.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this MRI method could help doctors better understand how type 2 diabetes affects multiple organs, potentially leading to earlier detection or monitoring.
What could go wrong: This is a small, early-stage study focused on measuring reproducibility, not on treating or curing diabetes. The results may not apply to all patients or scanners.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Beaver House

Oxford, OX1 2EH, United Kingdom
Gemini One

Oxford, OX4 2LL, United Kingdom
Oxford Centre for Magnetic Resonance

Oxford, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.